Insider Selling: CME Group (NASDAQ:CME) Director Sells 532 Shares of Stock

Posted by Francis Steltz on Nov 10th, 2026

CME Group Inc. (NASDAQ:CME – Get Free Report) Director Daniel Kaye sold 532 shares of the stock in a transaction that occurred on Monday, November 9th. The stock was sold at an average price of $304.17, for a total value of $161,818.44. Following the completion of the transaction, the director directly owned 4,313 shares of the company’s stock, valued at approximately $1,311,885.21. The trade was a 10.98% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link.

CME Group Price Performance

CME stock traded up $4.57 during trading on Tuesday, hitting $309.09. The company had a trading volume of 1,772,684 shares, compared to its average volume of 2,481,638. The company has a fifty day moving average price of $283.48 and a two-hundred day moving average price of $280.92. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The company has a market cap of $110.63 billion, a P/E ratio of 25.36, a P/E/G ratio of 3.76 and a beta of 0.15. CME Group Inc. has a fifty-two week low of $218.31 and a fifty-two week high of $329.16.

CME Group (NASDAQ:CME – Get Free Report) last released its quarterly earnings data on Wednesday, October 21st. The financial services provider reported $3.02 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.99 by $0.03. CME Group had a return on equity of 16.23% and a net margin of 63.33%. The firm had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.71 billion. During the same period in the prior year, the company posted $2.68 earnings per share. The business’s revenue for the quarter was up 10.6% compared to the same quarter last year. Equities research analysts expect that CME Group Inc. will post 12.34 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 30th. Stockholders of record on Friday, December 11th will be issued a $1.30 dividend. The ex-dividend date of this dividend is Friday, December 11th. This represents a $5.20 annualized dividend and a dividend yield of 1.7%. CME Group’s dividend payout ratio is presently 42.66%.

Institutional Trading of CME Group

A number of hedge funds and other institutional investors have recently made changes to their positions in CME. First Community Trust NA bought a new position in CME Group during the third quarter worth about $26,000. North Point Portfolio Managers Corp OH bought a new stake in shares of CME Group in the third quarter worth about $26,000. Mowery & Schoenfeld Wealth Management LLC bought a new position in shares of CME Group during the 2nd quarter valued at about $28,000. Compass Financial Management LLC grew its position in shares of CME Group by 471.4% in the 3rd quarter. Compass Financial Management LLC now owns 120 shares of the financial services provider’s stock valued at $31,000 after purchasing an additional 99 shares during the period. Finally, Main Street Group LTD acquired a new position in shares of CME Group in the 1st quarter valued at approximately $32,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on CME. Wall Street Zen raised shares of CME Group from a “sell” rating to a “hold” rating in a report on Saturday, October 31st. UBS Group boosted their price target on shares of CME Group from $270.00 to $310.00 and gave the company a “neutral” rating in a research report on Thursday, October 22nd. Wells Fargo & Company raised their price objective on shares of CME Group from $315.00 to $333.00 and gave the stock an “overweight” rating in a report on Thursday, October 22nd. JPMorgan Chase & Co. raised shares of CME Group from an “underweight” rating to an “overweight” rating and set a $367.00 price objective for the company in a report on Thursday, October 22nd. Finally, Barclays lifted their target price on shares of CME Group from $281.00 to $321.00 and gave the company an “equal weight” rating in a research note on Thursday, October 22nd. Ten investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $314.44.

Read Our Latest Research Report on CME

CME Group Company Profile

(Get Free Report)

CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.